ClinicalTrials.govpublic full text
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
retinopathy of prematurity, antiangiogenic therapy, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840035
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.